Document 0275 DOCN M9460275 TI Development and evaluation of an HIV-1 transfection-neutralization assay. DT 9408 AU Back NK; Smit L; Hogervorst E; van Wijk AC; Goudsmit J; Tersmette M; Department of Virology, University of Amsterdam, Academic Medical; Center, The Netherlands. SO J Acquir Immune Defic Syndr. 1994 Jun;7(6):531-8. Unique Identifier : AIDSLINE MED/94231457 AB We developed a transfection-neutralization assay for human immunodeficiency virus type 1 (HIV-1) infectious molecular clones. In this assay CD4 negative adherent cells, transfected in microtiter plates with fixed amounts of proviral DNA of molecular HIV-1 clones, are cocultivated with CD4 positive T cell lines or primary peripheral blood mononuclear cells (PBMC) in the presence of anti-HIV-1 sera or monoclonal antibodies (MAbs). Results obtained with this technique were reproducible and compared favorably with a conventional cell-free infection inhibition assay. The transfection-neutralization assay obviates the need for virus stock preparation and, therefore, is particularly suitable for the evaluation of HIV-1 clones with slow replication kinetics and of recombinant chimeric HIV-1 clones inclined to undergo additional mutations during stock preparation. The potential value of this assay for the analysis of the specificity of neutralizing sera and MAbs was demonstrated in experiments with V3 chimeric molecular clones. DE Amino Acid Sequence Antibody Specificity Antigenic Determinants/ANALYSIS Cell Line Cells, Cultured Chimeric Proteins/CHEMISTRY/GENETICS/IMMUNOLOGY Cloning, Molecular DNA, Viral/PHYSIOLOGY Evaluation Studies Hela Cells Human HIV Antibodies/*BLOOD/IMMUNOLOGY HIV Envelope Protein gp120/CHEMISTRY/GENETICS/IMMUNOLOGY HIV Infections/IMMUNOLOGY HIV-1/GENETICS/*IMMUNOLOGY Immune Sera/IMMUNOLOGY Leukocytes, Mononuclear/MICROBIOLOGY Molecular Sequence Data *Neutralization Tests Peptide Fragments/CHEMISTRY/GENETICS/IMMUNOLOGY Proviruses/GENETICS/IMMUNOLOGY Reproducibility of Results Sensitivity and Specificity Sequence Alignment Support, Non-U.S. Gov't *Transfection Virus Replication/IMMUNOLOGY JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).